SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ghose, K.
Right arrow Articles by Taylor, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ghose, K.
Right arrow Articles by Taylor, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hypercupraemia Induced by Antiepileptic Drugs

K. Ghose

Lingfield Hospital School, Lingfield, Surrey

A. Taylor

Robens Institute, University of Surrey, Guildford

1 Serum copper and zinc levels were measured in 84 treated male epileptics, aged between 6 and 18 years, by an atomic absorption spectroscopic method. These patients were selected randomly from a residential special school. Twenty drug-free healthy but educationally subnormal (ESN) male subjects of similar age group from the same school acted as controls.

2 No abnormality in serum zinc level was observed.

3 In nineteen (22.6%) epileptics, copper levels were above the upper level of normal range (20.5 µmol/l), whereas this was only marginally elevated (20.8 µmol/l) in one (5%) ESN subject.

4 The mean copper level in all epileptics was higher than the controls (P<0.01), but there was no difference between the epileptics treated with sodium valproate alone and the ESN group.

5 The patients who were receiving carbamazepine either as monotherapy or in combination with other drugs except phenytoin, had higher mean copper levels than the controls (P<0.01). A similar observation was made in relation with phenytoin polytherapy (but excluding carbamazepine).

6 There also appeared to be an association between the high serum copper levels and diffuse/generalized electroencephalographic changes (P < 0.001). Some antiepileptic drugs, particularly carbamazepine, can produce such electroencephalographic abnormalities.

7 It is concluded that hypercupraemia observed in these treated epileptics were related to the induction of caeruloplasmin synthesis by phenytoin and carbamazepine.

Human & Experimental Toxicology, Vol. 2, No. 3, 519-529 (1983)
DOI: 10.1177/096032718300200308


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement